420 views | 2 years ago
Richard Schilsky, MD, explains how comprehensive genomic profiling is qualifying patients with cancer to participate in clinical trials that provide treatment options for them that they might not otherwise...
1194 views | 2 years ago
Atocha Romero, PharmD, PhD, explains the value of liquid biopsy-based comprehensive genomic profiling. Dr. Romero provides an overview of the results of the NADIM II clinical trials and discusses ctDNA...
402 views | 2 years ago
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a RET fusion by comprehensive genomic profiling....
582 views | 2 years ago
With the help of the NextSeq™ 2000, Zymo Research is delivering cost-effective and timely sequencing services to help scientist pursue more of the world’s biggest questions and keep their research moving...
681 views | 2 years ago
Illumina DNA Prep with Enrichment Dx is an FDA-regulated and EU IVDR 2017/746-compliant solution for targeted sequencing in diagnostic applications. This Dx library preparation solution delivers validated...
520 views | 2 years ago
Prof. Tony Mok discusses the benefits of biomarker testing for patients with lung cancer. He provides an overview of the value of genomic profiling in the first-line setting and highlights the importance...
1239 views | 2 years ago
The Ontario Institute for Cancer Research (OICR) is working to better understand tumor biology and improve cancer care through the use of genomics. Their partner at Princess Margaret Cancer Centre,...
277 views | 2 years ago
El Perfil Genómico Integral (PGI) del ADN tumoral circulante (ctDNA) obtenido mediante biopsia líquida sanguínea proporciona resultados importantes para informar la selección de terapias posteriores....